Aquatic Capital Management’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$760K Buy
133,779
+14,526
+12% +$71K 0.03% 640
2026
Q1
$512K Buy
+119,253
New +$664K 0.01% 747
2025
Q1
Sell
-31,431
Closed -$83.6K 1526
2024
Q4
$83.6K Buy
+31,431
New +$80.9K ﹤0.01% 1095
2023
Q2
Sell
-500
Closed -$1K 1631
2023
Q1
$1K Sell
500
-7,100
-93% -$14.4K ﹤0.01% 1194
2022
Q4
$14K Buy
+7,600
New +$15.4K ﹤0.01% 1190

Other funds holding NUVB

Aquatic Capital Management's NUVB Position: Q2 2026 in Review

Aquatic Capital Management increased its Nuvation Bio (NUVB) stake by 12% in Q2 2026, buying an estimated $71K and bringing the position to 133,779 shares worth $760K. The position accounts for 0.03% of the portfolio, ranked #640.

Aquatic Capital Management first reported a position in NUVB in Q4 2022 and has held it in 5 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Aquatic Capital Management held 133,779 shares of Nuvation Bio worth $760K as of Q2 2026.
  • Aquatic Capital Management bought 14,526 Nuvation Bio shares in Q2 2026, an estimated $71K.
  • Nuvation Bio made up 0.03% of Aquatic Capital Management's portfolio in Q2 2026, its #640 holding.
  • Aquatic Capital Management first reported a position in Nuvation Bio in Q4 2022 and has held it in 5 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.